2024
Why selective screening for asymptomatic carotid stenosis is currently appropriate: a special report
Paraskevas K, Dardik A, Schermerhorn M, Liapis C, Mansilha A, Lal B, Gray W, Brown M, Myrcha P, Lavie C, Zeebregts C, Secemsky E, Saba L, Blecha M, Gurevich V, Silvestrini M, Blinc A, Svetlikov A, Fernandes e Fernandes J, Schneider P, Gloviczki P, White C, AbuRahma A. Why selective screening for asymptomatic carotid stenosis is currently appropriate: a special report. Expert Review Of Cardiovascular Therapy 2024, 22: 159-165. PMID: 38480465, DOI: 10.1080/14779072.2024.2330660.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsScreening programMass screening programPopulation-wide screening programsRisk factor modificationHigh riskHigh risk of strokeMyocardial infarctionInitiation of preventive measuresRisk of strokeIntensive medical therapyAsymptomatic carotid artery stenosisFactor modificationCost-effectiveLifestyle measuresPrevent future strokeAsymptomatic carotid stenosisTargeted screeningCarotid artery stenosisFuture strokeScreening of populationsCarotid revascularization proceduresProphylactic carotid interventionMedical therapyPreventive measuresCV events
2023
What are the benefits and drawbacks of statins in carotid artery disease? A perspective review
Said S, Dardik A, Chaar C. What are the benefits and drawbacks of statins in carotid artery disease? A perspective review. Expert Review Of Cardiovascular Therapy 2023, 21: 763-777. PMID: 37994875, DOI: 10.1080/14779072.2023.2286011.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsCarotid artery diseaseCarotid artery stenosisSide effectsArtery diseaseArtery stenosisAlternative therapiesSymptomatic carotid artery stenosisAtherosclerotic carotid artery diseaseMultiple international guidelinesAcute ischemic strokeImpact of statinsGenetic polymorphismsStatin side effectsWarrants close monitoringDrug of choiceSerious side effectsMechanism of statinStatin therapyCarotid revascularizationIschemic strokePCSK9 inhibitorsLipid controlStroke incidencePatient selectionClinical efficacy